Endothelium-derived endothelin-1 mediates sickle cell nephropathy
Function · 01.04.2026 · 7 (2)
DOI: 10.1152/function.001.2026 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Function, erschienen am 01.04.2026. Verfasst von Malgorzata Kasztan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardio Renal Physiology & Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alaba…. Hauptthemen laut MEDLINE: Endothelin-1, Anemia, Sickle Cell, Kidney Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Sickle cell nephropathy (SCN) significantly shortens the life expectancy of patients with sickle cell disease (SCD). We previously reported that endothelin-1 (ET-1) and endothelin A receptor (ET A ) are upregulated in SCN, and ET A antagonism mitigates SCN early in the disease progression in a humanized mouse model of SCD. We hypothesized that endothelium-derived ET-1 mediates the progression of SCN and T cell inflammation in the kidney of SCD mice. To test this hypothesis, we first used allogenic bone marrow transplantation from humanized sickle cell mice (HbSS) into endothelial-derived ET-1 knockout (VEET KO) mice, revealing that endothelial-derived ET-1 mitigates SCN and regulates the renal inflammatory response and T cell infiltration. Second, using young (4–5 mo old) and middle-aged (10–15 mo old) HbSS mice lacking endothelial-specific ET-1 (HbSS-VEET KO), we found a temporal maintenance of glomerular filtration rate, reduced infiltration of T cells to the kidney, and reduced progression of SCN. Furthermore, 2-wk ET A antagonism in middle-aged HbSS mice reduced infiltration of T cells. Finally, flow cytometric analyses revealed blunting of kidney T helper 17 (T H 17) cells without a change in kidney T regulatory cells in HbSS-VEET KO mice, suggesting T cell subset-specific regulation by endothelial-derived ET-1 signaling. In vitro studies showed that ET A antagonism directly inhibits T H 17 polarization and IL-17A production, suggesting that in established sickle cell disease, the ET A receptor-T H 17 cell axis may play a key role in maintenance of fibrosis in SCN. Taken together, these data indicate that endothelial-derived ET-1 mediates the progression of SCN and strengthens the rationale for targeting ET-1 signaling as a new therapeutic approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Cardio Renal Physiology & Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States.
- Division of Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, United States.
- Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
ORCID-Profile: Jennifer S Pollock
Förderung
- NIDDK NIH HHS
- NIH HHS
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Kasztan, M., Molina, P. A., Fox, B. M., Saurage, E., Colson, J. C., Pollock, D. M., & Pollock, J. S. (2026). Endothelium-derived endothelin-1 mediates sickle cell nephropathy. Function, 7(2). https://doi.org/10.1152/function.001.2026
Vancouver
Kasztan M, Molina PA, Fox BM, Saurage E, Colson JC, Pollock DM, et al. Endothelium-derived endothelin-1 mediates sickle cell nephropathy. Function. 2026;7(2). doi:10.1152/function.001.2026
BibTeX
@article{Kasztan2026,
author = {Kasztan, Malgorzata and Molina, Patrick A and Fox, Brandon M and Saurage, Elizabeth and Colson, Jackson C and Pollock, David M and Pollock, Jennifer S},
title = {Endothelium-derived endothelin-1 mediates sickle cell nephropathy},
journal = {Function},
year = {2026},
volume = {7},
number = {2},
doi = {10.1152/function.001.2026}
}
EUVIMED